Computational study demonstrates multimodal biological data integration for cancer survival prediction, suggesting improved prognostic accuracy over single-omics models.
This preprint presents computational techniques for cancer prognosis using the integration of multiple biological data modalities, including genomic, transcriptomic, methylation, and potentially proteomic information. The proposed framework addresses the challenges of heterogeneous data scales, high dimensionality, limited patient cohorts, and overfitting in multi-omics modelling. The methodology combines modality-specific preprocessing, variational multimodal encoding, shared latent representations, patient-similarity graph reasoning, and survival prediction using a Cox proportional hazards objective. Performance is evaluated against single-omics baselines using survival-analysis measures including concordance index, integrated Brier score, time-dependent AUC, Kaplan–Meier analysis, and log-rank testing. Interpretability techniques are also incorporated to identify biological signals contributing to prognosis predictions.
No takes yet. Share an insight, caveat, or question.
Adishree Gupta (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: